Popular media has described CRISPR as an “amazing miracle tool”. While scientists might shy away from using the word “miracle”, the technology is still amazing with the potential real-world applications. CRISPR technology is a powerful genome editing tool adapted from the natural defense mechanism of bacteria against viruses. The enzymes involved in CRISPR reactions have the ability to cut nucleic acid (DNA or RNA) in a highly targeted manner. Researchers can exploit this ability of CRISPR enzymes to remove, add, or alter sections of the DNA/RNA sequence towards a broad set of applications, from genome editing to molecular diagnostics.
SignalChem has a wide variety of CRISPR-related products to help researchers. This presentation will review what CRISPR is and its advantages, the enzymes involved in a typical CRISPR reaction, and a specific assay application using CRISPR.
12:30pm – 3:30pm, Tuesday 22nd November 2022
Perham Seminar Room, Sanger Building,
80 Tennis Court Road, Cambridge, CB2 1GA
SignalChem is a biotech company focused on the research, development and production of innovative and high-quality human recombinant cell signalling products. Throughout the years, Signalchem has capitalized on its core expertise in cellular signalling, molecular biology and protein biochemistry to generate more than 2,000 functional protein products and has established itself as the leader in industry to produce highly active human recombinant signalling enzymes, especially protein kinases, disease-related mutant kinases, lipid kinases, epigenetic enzymes, ubiquitination-related enzymes and neurodegenerative disease-related enzymes and proteins. SignalChem strives to support scientists in academia, pharma and biotech companies around the world by creating effective research tools to advance the basic research in life sciences and to facilitate the efforts in drug discovery and development.